← back to search

Jiashin Wu

Guangzhou University of Chinese Medicine · CN
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research focused on Heart failure and Protein kinase B, with related work in Pressure overload, Pharmacology, In vivo. Notable publications include 'The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice', 'Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice', and 'Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes'.
h-index
citations
232
works
12
NIH funding
primary concept
email

Recent publications

Xiaoyu Jiangzhi capsule protects against heart failure via Ca2+/CaMKII signaling pathways in mice
Journal of Traditional Chinese Medical Sciences 2022cited by 2position: middledoi
Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways
Journal of Ethnopharmacology 2020cited by 16position: middledoi
Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice
American Journal Of Pathology 2018cited by 11position: middledoi
Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes
Scientific Reports 2017cited by 36position: middledoi
Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia <i>in vivo</i> and <i>in vitro</i>
Oncotarget 2017cited by 16position: middledoi
The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice
American Journal Of Pathology 2016cited by 50position: middledoi
Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice
PLoS ONE 2016cited by 44position: middledoi
Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivo
Chinese Journal of Integrative Medicine 2016cited by 27position: lastdoi
Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
Evidence-based Complementary and Alternative Medicine 2014cited by 7position: middledoi
6-year post-PCI follow-up of a 110-year myocardial infarction patient: A case report
International Journal of Cardiology 2014cited by 5position: middledoi
Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice
Evidence-based Complementary and Alternative Medicine 2013cited by 12position: middledoi
Multicentric Granular Cell Tumors With Heart Involvement: A Case Report
Journal of Clinical Oncology 2012cited by 6position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jianyong Qi · Guangzhou University of Chinese Medicine9 papers (2012–2020)Juan Yu · First People's Hospital of Yunnan Province7 papers (2013–2022)Minzhou Zhang · Guangzhou University of Chinese Medicine7 papers (2012–2022)Yafang Tan · Guangzhou University of Chinese Medicine5 papers (2016–2022)Liheng Guo · Guangzhou University of Chinese Medicine4 papers (2013–2016)Lei Wang · Guangzhou University of Chinese Medicine2 papers (2013–2016)Donghui Huang · Guangzhou University of Chinese Medicine2 papers (2013–2016)Miao Zhou · Ningbo University2 papers (2013–2014)Minzhou Zhang · Guangzhou University of Chinese Medicine2 papers (2014–2017)Wenjun Pan · Guangzhou University of Chinese Medicine2 papers (2017–2020)Wen Xu · Guangzhou University of Chinese Medicine2 papers (2017–2020)Weiwang Gu · Center for Cancer Research2 papers (2016–2017)Jiayou Wang · Jiangsu University of Science and Technology2 papers (2016–2018)Min You · Nanjing University of Chinese Medicine2 papers (2016–2018)Renshan Chen · Guangzhou University of Chinese Medicine2 papers (2016–2017)Dancai Fan · Guangzhou University of Chinese Medicine2 papers (2017–2020)Jianwei Wu · Guangzhou University of Chinese Medicine1 papers (2022–2022)Xin Huang · Shihezi University1 papers (2016–2016)Huquan Yin · University of South Florida1 papers (2016–2016) · 1 papers (2012–2012)